King Faisal Specialist Hospital and Research Centre präsentiert Gesundheitsinnovationen und -lösungen auf der Global Health Exhibition

RIAD, Saudi–Arabien, Oct. 29, 2023 (GLOBE NEWSWIRE) — Das King Faisal Specialist Hospital and Research Centre (KFSH&RC) nimmt als strategischer Gesundheitspartner an der Global Health Exhibition 2023 teil, die morgen in Riad beginnt und drei Tage dauert.

Das Krankenhaus wird in seinem Pavillon, der an der das Forum begleitenden Ausstellung teilnimmt, seine wichtigsten Innovationen und Gesundheitslsungen im Rahmen seiner strategischen Ausrichtung prsentieren, die darauf abzielt, seine Position als Pionier des Wissens durch Bildung, Forschung, Innovation und eine Gesundheitsversorgung auf hchstem Qualitts– und Sicherheitsniveau zu strken.

Seine Exzellenz der CEO des King Faisal Specialist Hospital and Research Centre, Dr. Majid Ibrahim Al Fayyadh, erklrte bei dieser Gelegenheit: Das Knigreich Saudi–Arabien arbeitet daran, seine Position als weltweit fhrendes Land im Bereich der Innovation zu festigen, indem es ein dynamisches kosystem frdert, das die neuesten Technologien einbezieht, die Zukunft des Gesundheitswesens untersttzt und das Land als weltweites Ziel etabliert.

Dr. Majid Ibrahim Al Fayyadh betonte, dass die Teilnahme des KFSH&RC an der Ausstellung im Kontext seines Engagements steht, Innovationen im Gesundheitssektor von der nationalen bis zur globalen Ebene voranzutreiben und alles zu untersttzen, was dazu beitrgt, eine Gesundheitsversorgung auf hchstem Niveau und die beste Patientenerfahrung zu bieten.

Das KFSH&RC stellt den Besuchern der Ausstellung seine verschiedenen Gesundheitsinnovationen und –lsungen und deren Auswirkungen auf die Verbesserung der Ergebnisse der Gesundheitsversorgung und der Patientenerfahrung sowie auf die Verbesserung der Betriebseffizienz in verschiedenen medizinischen Bereichen vor, darunter die Patientenreise, die biomedizinische Weltraumforschung, die Genommedizin, das Kapazittsmanagement, die radiopharmazeutische Arzneimittelherstellung und die Behandlung mit T–Zellen (CAR–T–Zellen).

Das KFSH&RC ist bereit, seine Innovationen zu prsentieren und seine Fhrungsrolle im biomedizinischen Raum zu demonstrieren. Dies zeigt sich durch die fhrende Rolle des Krankenhauses bei der berwachung von vier Forschungsexperimenten im Bereich der Zellwissenschaften, die im Bereich der Zellforschung durchgefhrt wurden, was die Vorreiterrolle des Krankenhauses bei der Frderung internationaler Innovationen unterstreicht. Darber hinaus wird das Krankenhaus sein T–Zell–Re–Engineering–Behandlungsprogramm fr Krebspatienten vorstellen, was eine bedeutende Verbesserung der spezialisierten medizinischen Versorgung im Knigreich bedeutet. Dieser Fortschritt fhrt auch zu einer geringeren finanziellen und gesundheitlichen Belastung, da die Patienten nicht mehr gezwungen sind, sich im Ausland behandeln zu lassen.

Das KFSH&RC gilt als eines der weltweit fhrenden Zentren fr spezialisierte Gesundheitsversorgung, als Vorreiter in Sachen Innovation und als fortschrittliches medizinisches Forschungs– und Ausbildungszentrum. Darber hinaus ist sie bestrebt, in Zusammenarbeit mit wichtigen lokalen, regionalen und internationalen Einrichtungen medizinische Technologien zu entwickeln und die Gesundheitsversorgung weltweit zu verbessern, um in den Bereichen Klinik, Forschung und Bildung Dienstleistungen von Weltrang zu erbringen.

Kontaktinformationen:
kfshrc@mcsaatchi.com

Ein Foto zu dieser Mitteilung ist verfgbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/5b3530bb–ea2d–42ee–a358–4c2fe3f8630e


GLOBENEWSWIRE (Distribution ID 8967950)

L’hôpital spécialisé et centre de recherche King Faisal présente ses dernières innovations et solutions de santé à l'occasion de la Global Health Exhibition

RIYAD, Arabie Saoudite, 29 oct. 2023 (GLOBE NEWSWIRE) — L'hpital spcialis et centre de recherche King Faisal (ci–aprs KFSH&RC ) est un partenaire sant stratgique de l'dition 2023 de la Global Health Exhibition qui dbute demain Riyad pour une dure de trois jours.

Dans l'espace d'exposition qui lui est rserv, le pavillon KFSH&RC mettra en vitrine les dernires innovations majeures de l'hpital, et ses plus importantes solutions de sant. L'vnement s'inscrit dans la droite ligne des orientations stratgiques du KFSH&RC visant renforcer sa marque de pionnier du savoir acquis par l'ducation, la recherche, et l'innovation, mais aussi fournir les soins de sant les plus qualitatifs et les plus scuriss.

Son Excellence le Dr Majid Ibrahim Al Fayyadh, directeur de l'hpital spcialis et centre de recherche King Faisal, a dclar cette occasion que : Le Royaume d'Arabie Saoudite s'efforce de consolider sa position de leader mondial de l'innovation travers le dveloppement d'un cosystme dynamique en privilgiant les technologies les plus rcentes pour participer l'avenir des soins de sant et devenir une destination mondiale incontournable .

Le Dr Majid Ibrahim Al Fayyadh a soulign que la participation du KFSH&RC la Global Health Exhibition fait cho son engagement faire voluer l'innovation en sant du plan national l'chelle mondiale, et soutenir tout ce qui contribue tablir les meilleurs soins de sant et une exprience optimale pour les patients.

KFSH&RC prsente ses diffrentes innovations et solutions sant aux visiteurs de l'exposition, ainsi que leurs effets positifs sur l'amlioration des rsultats en matire de soins de sant et d'exprience des patients. KFSH&RC dmontre galement les bienfaits de ses solutions sur l'efficacit oprationnelle de nombreux domaines thrapeutiques, et notamment le vcu des patients, la recherche biomdicale spatiale, la mdecine gnomique, la gestion des capacits de prise en charge, la production de mdicaments radiopharmaceutiques, et la thrapie par lymphocytes T (cellules CAR–T).

Le KFSH&RC est prt prsenter ses innovations et dmontrer son leadership en recherche biomdicale spatiale, qui s'illustre notamment par la supervision de quatre conduites de recherche en sciences cellulaires dans l'espace, et qui accentue le rle prcurseur de l'hpital dans la promotion de l'innovation internationale. Par ailleurs, l'hpital prsentera son programme de ringnierie des lymphocytes T pour les patients atteints de cancer, qui amliore considrablement les soins mdicaux spcialiss dispenss au sein du Royaume. Cette avance se traduit galement par une rduction des charges financires et sanitaires, les patients n'ayant ainsi plus besoin de se faire soigner l'tranger.

KFSH&RC compte parmi les plus minentes institutions du monde en matire de prestation de soins de sant spcialiss. Pionnier de l'innovation, l'hpital est galement un centre de recherche et d'ducation mdicale avanc. Il s'efforce galement de dvelopper des technologies mdicales et de faire voluer les soins de sant l'chelle mondiale en partenariat avec de grandes institutions locales, rgionales, et internationales, pour atteindre un service hors pair dans les domaines cliniques, de recherche et d'ducation.

Coordonnes :
kfshrc@mcsaatchi.com

Une photo accompagnant cette annonce est disponible l'adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/5b3530bb–ea2d–42ee–a358–4c2fe3f8630e


GLOBENEWSWIRE (Distribution ID 8967950)

King Faisal Specialist Hospital and Research Centre Apresenta Suas Inovações e Soluções de Saúde na Global Health Exhibition

RIADE, Arábia Saudita, Oct. 29, 2023 (GLOBE NEWSWIRE) — O King Faisal Specialist Hospital and Research Centre (KFSH&RC) est participando como parceiro de sade estratgico na Global Health Exhibition 2023 de trs dias, com incio amanh em Riade.

O hospital, no seu pavilho da exposio que acompanha o frum, mostrar suas inovaes e solues de sade mais proeminentes no mbito das suas direes estratgicas destinadas a fortalecer sua posio como pioneiro do conhecimento por meio da educao, pesquisa, inovao e prestao de cuidados de sade com os mais altos nveis de qualidade e segurana.

Sua Excelncia Dr. Majid Ibrahim Al Fayyadh, CEO do King Faisal Specialist Hospital and Research Centre, falou sobre o evento: O Reino da Arbia Saudita est trabalhando para consolidar a sua posio como lder global no campo da inovao, promovendo um ecossistema dinmico que abraa as mais recentes tecnologias, apoiando o futuro dos cuidados de sade e se estabelecendo como um destino mundial.

O Dr. Majid Ibrahim Al Fayyadh salientou que a participao do KFSH&RC na exposio est alinhada ao contexto do seu compromisso de promover a inovao no setor da sade, do nvel nacional ao global, e de apoiar tudo o que contribui para proporcionar os mais altos nveis de cuidados de sade e a melhor experincia para o paciente.

O KFSH&RC apresenta aos visitantes da exposio suas vrias inovaes e solues de sade e seu impacto na melhoria dos resultados dos cuidados de sade e da experincia do paciente, e na melhoria da eficincia operacional em vrios campos mdicos, incluindo a jornada do paciente, pesquisa biomdica espacial, medicina genmica, gerenciamento de capacidade, produo de medicamentos radio farmacuticos e tratamento com clulas T (clulas CAR–T).

O KFSH&RC est pronto para exibir suas inovaes, demonstrando sua liderana na pesquisa espacial biomdica. Isso ressaltado pela sua liderana na superviso de quatro experimentos de pesquisa em cincias celulares conduzidos no espao, solidificando o papel pioneiro do hospital na promoo da inovao internacional. Alm disso, o hospital apresentar seu programa de tratamento com reengenharia de clulas T para pacientes com cncer, um aprimoramento significativo no atendimento mdico especializado dentro do Reino. Esse avano tambm se traduz na reduo dos encargos financeiros e de sade, uma vez que os pacientes no so mais obrigados a procurar tratamento no exterior.

O KFSH&RC considerado um dos mais proeminentes do mundo na prestao de cuidados de sade especializados, um pioneiro em inovao e um centro avanado de pesquisa e educao mdica. O hospital tambm trabalha no desenvolvimento tecnologias mdicas e disseminao dos cuidados de sade em todo o mundo em parceria com as principais instituies locais, regionais e internacionais, para alcanar um servio de classe mundial nos campos clnico, de pesquisa e educacional.

Informaes de Contato:
kfshrc@mcsaatchi.com

Foto deste comunicado disponvel em https://www.globenewswire.com/NewsRoom/AttachmentNg/5b3530bb–ea2d–42ee–a358–4c2fe3f8630e


GLOBENEWSWIRE (Distribution ID 8967950)

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its pioneering journey and prospects in space biomedical research and its role in enhancing human health at the Global Health Exhibition, where KFSH&RC is also participating as a strategic healthcare partner.

At the Exhibition, KFSH&RC delves into its groundbreaking experience leading four research experiments in cell sciences in space. These experiments encompass testing the immune cell response to inflammation in space, monitoring the activity of thousands of genes in immune cells exposed to inflammation over time, and tracking the changes in the lifespan of ribonucleic acid (mRNA) between space and Earth. Additionally, the pavilion simulates the inflammatory response to drug treatment using an immune cell model to explore its potential applications for prevention and early treatment.

The aim of these research experiments, conducted in collaboration with the Saudi Space Authority, as part of the scientific mission of Saudi astronauts Rayyanah Barnawi and Ali Al–Qarni to the International Space Station (ISS), is to contribute to exploratory research and its applications in space medicine to enhance the safety of space explorers and utilize the knowledge gained for the benefit the patient community globally.

The scientific experiments lasted for four days and were overseen by the research team led by Dr. Khaled Saad Abu Khubrah, Head of the Department of Molecular Biomedicine and Research at KFSH&RC, along with Dr. Wijdan Al–Ahmadi from KFSH&RC and Dr. Edward Hattie from the BioServe Space Technologies Center in Colorado, USA.

KFSH&RC is actively pursuing further research in space biomedical science to gain a more comprehensive understanding of the effects of gravity deficiency and cosmic radiation on the human body. They aim to leverage the unique space environment, which provides opportunities for medical experiments that are not feasible on Earth. This includes studying how cells and tissues grow in microgravity conditions, potentially leading to groundbreaking discoveries in disease treatments and opening new avenues in space medicine.

KFSH&RC is globally renowned for its specialized healthcare services and its leadership in innovation. It stands as an advanced centre for medical research and education, aiming to advance medical technologies and raise the standard of healthcare worldwide through partnerships with prominent local, regional, and international institutions in clinical, research, and educational fields.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/78eba5fa–19d6–437c–ab42–c9a09636e91e

https://www.globenewswire.com/NewsRoom/AttachmentNg/c30c198b–dd13–4d48–8b8c–6667eda49b45


GLOBENEWSWIRE (Distribution ID 8967907)

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World's First Fully Robotic Living Donor Liver Transplant

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) — In a historic achievement, the Organ Transplant Center of Excellence (OTCoE) team at King Faisal Specialist Hospital & Research Centre (KFSH&RC) has successfully performed the world's first fully robotic living donor liver transplant in the Kingdom of Saudi Arabia""a move that solidifies KFSH&RC's position as a global leader in minimally invasive transplant surgery.

KFSH&RC's pioneering approach employed state–of–the–art robotic technology to conduct both donor and recipient surgeries with precision and minimal invasiveness, eliminating the need for a hybrid approach. While other centres offer minimally invasive liver transplants using mixed techniques, KFSH&RC is the only centre to complete a fully robotic living donor liver transplant surgery successfully.

This accomplishment represents a significant leap forward in the history of transplantation, a testament to the centre's commitment to advanced practices that enhance healthcare outcomes, improve the patient experience, and boost hospital operational efficiency. It has also led to a reduction in the risk of complications, recovery time, and the length of hospital stays.

As a strategic health partner at the Global Health Exhibition held in Riyadh from October 29 to October 31, KFSH&RC is showcasing its latest innovations at the forum. Attendees will gain insights into the OTCoE's expertise in applying cutting–edge technologies to expand healthcare possibilities.

KFSH&RC has set records in successfully conducting reciprocal kidney transplants, a medical approach that facilitates kidney transplants between two donors from different families simultaneously. In 2022, the program achieved a remarkable milestone by completing 91 reciprocal transplants, surpassing its international counterparts.

KFSH&RC's OTCoE is a pioneer in the Kingdom, representing one of the most advanced and comprehensive facilities for multi–organ transplantation in the Middle East. Its services encompass kidney, liver, lung, pancreas, and intestine transplants, collectively called solid organ transplantation.

KFSH&RC is globally renowned for its exceptional contributions to specialized healthcare, commitment to innovation, and dedication to advanced medical research and education. Furthermore, KFSH&RC is steadfast in its pursuit of developing medical technologies and elevating the standard of healthcare globally by collaborating with major local, regional, and international institutions. It is committed to delivering world–class clinical, research, and educational services.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/888a9b0a–3cd2–4186–ab5e–b44eb8f0d9cb

https://www.globenewswire.com/NewsRoom/AttachmentNg/250c97ba–0d78–4a24–83a5–73e063b3366b


GLOBENEWSWIRE (Distribution ID 8967901)

مركز زراعة الأعضاء بالتخصصي: سجلنا الريادة عالمياً بأول زراعة كبد كاملة بالروبوت

الرياض: 29 أكتوبر

يواصل مستشفى الملك فيصل التخصصي ومركز الأبحاث تميّزه في تقديم خدمات الرعاية الصحية التخصصية، ويعد مركز التميز لزراعة الأعضاء بالمستشفى أحد أبرز المرافق التي سجّلت ريادتها في تقديم الخدمات للمرضى وفق أعلى معايير الجودة والسلامة، محققاً خلال العام الحالي منجزاً طبياً غير مسبوق؛ من خلال إجراء أول عملية زراعة كبد كاملة من متبرع حي باستخدام الروبوت على مستوى العالم.

وتفرد "التخصصي" بتنفيذ الزراعة باستخدام الروبوت في مرحلتي الاستئصال والزراعة، وصولاً إلى إنجاز خمسة حالات مختلفة، بينما لا تزال المراكز الطبية حول العالم تعتمد على الجراحة التقليدية أو نهج يدمج بين الجراحتين التقليدية والروبوتية في آن واحد، حيث يمثل هذا المنجز نقلة نوعية لتاريخ زراعة الأعضاء، ونهجاً طبياً حديثاً يعمل على تعزيز جودة النتائج، وتحسين تجربة المرضى، وكفاءة التشغيل للمستشفى، نظراً لما يقدمه من تقليل لاحتمالية حدوث المضاعفات، وتقليل مدة الشفاء، والبقاء في المستشفى.

وبالتزامن مع تواجده كشريك استراتيجي صحي بملتقى الصحة العالمي المنعقد في العاصمة الرياض خلال الفترة 29–31 أكتوبر الجاري، يستعرض مستشفى الملك فيصل التخصصي ومركز الأبحاث لزوار جناحه بالمعرض المصاحب؛ تجربة مركز التميز لزراعة الأعضاء في تطبيق أحدث التقنيات بوصفه رائداً عالمياً  في مجاله.

وسجّل "التخصصي" كفاءته في تنفيذ برنامج زراعة الكلى التبادلي، وهو نهج طبي يقوم على زراعة الكلى بشكل تبادلي بين متبرعين اثنين من عائلتين مختلفين في وقت تزامني، ليحقق البرنامج رقماً قياسياً في عدد الزراعات التبادلية التي أجرها خلال العام 2022، والتي بلغت 91 حالة، متفوقاً بذلك على نظرائه من المراكز الطبية العالمية.

ويعتبر المركز الأول من نوعه على مستوى المملكة ودول الخليج العربي، ومن أكثر المرافق تطوراً وشمولية في زراعة الأعضاء المتعددة في الشرق الأوسط، حيث يقدم خدمات الزراعة لكل من أعضاء الكلى، والكبد، والرئة، والبنكرياس، والأمعاء، والتي تعرف بزراعة الأعضاء الصلبة.

ويُعد مستشفى الملك فيصل التخصصي ومركز الأبحاث، من بين الأبرز عالمياً في تقديم الرعاية الصحية التخصصية ورائداً في الابتكار، ومركزًا متقدمًا في البحوث والتعليم الطبي، كما يسعى لتطوير التقنيات الطبية والارتقاء بمستوى الرعاية الصحية على مستوى العالم، وذلك بالشراكة مع كبار المؤسسات المحلية والإقليمية والدولية، لتحقيق خدمة عالمية المستوى في المجالات السريرية والبحثية والتعليمية.

Restricted     مقيد    

GLOBENEWSWIRE (Distribution ID )

King Faisal Specialist Hospital and Research Centre Announces Rapid Whole Genome Sequencing Service

RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — In a groundbreaking development for the Middle East, King Faisal Specialist Hospital and Research Centre (KFSH&RC) has introduced a service called Rapid Whole–Genome Sequencing (rWGS) as part of its healthcare solutions. This service is designed to help doctors diagnose rare and genetic disorders, particularly in critically ill newborns, who require fast and precise identification of their conditions.

The Rapid Whole Genome Sequencing service is invaluable for newborns with rare diseases, as it helps them avoid the often lengthy process of tests and treatments that can stretch for months or even years without a precise diagnosis. This increases the chances of survival and reduces the overall healthcare cost by minimizing hospital admissions, unnecessary tests, and medical care.

Remarkably, the hospital has reduced the time required for this genetic testing from the typical two–month duration to less than 35 hours. Response time is paramount when planning healthcare for critically ill newborns, and swift delivery of test results ensures a prompt and tailored medical response, preventing delays that could otherwise lead to worsening the patient's condition or even death.

As part of its participation in the Global Health Summit, where KFSH&RC plays a vital role as a strategic healthcare partner, the hospital shares details about the Rapid Whole Genome Sequencing service at its exhibition booth. The hospital's cutting–edge capabilities include analyzing up to 99% of DNA sequences from patient blood samples, along with several innovative healthcare solutions.

The comprehensive genetic composition examination involves a streamlined four–step process. First, the DNA is broken down into manageable segments. Then, it is encoded with a barcode–like symbol for easy identification, similar to tracking products in a store. The examination itself is conducted using specialized equipment. Finally, advanced computer systems and software compare these sequences, identifying differences in DNA sequences and pinpointing the genetic mutations responsible for diseases.

KFSH&RC provides the highest level of healthcare and offers the best possible patient experience within an integrated educational and research environment. It collaborates and shares expertise with leading local, regional, and international institutions to provide a globally competitive service in clinical, research, and educational fields.

Globally renowned for its specialized healthcare, KFSH&RC is a pioneer in medical innovation and a hub for advanced medical research and education. It is committed to advancing medical technologies and raising the standard of healthcare worldwide through partnerships with top local, regional, and international institutions in clinical, research, and educational sectors.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at:

https://prdesk.globenewswire.com/api/ResourceLibraryFile/DownloadFile?source=pnr&Id=59bc8aa4–5f6d–432a–b4e9–c26544e9aa6d

https://prdesk.globenewswire.com/api/ResourceLibraryFile/DownloadFile?source=pnr&Id=76f80d26–8e56–42df–b95a–c8cdab80e449 

GLOBENEWSWIRE (Distribution ID )

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its pioneering journey and prospects in space biomedical research and its role in enhancing human health at the Global Health Exhibition, where KFSH&RC is also participating as a strategic healthcare partner.

At the Exhibition, KFSH&RC delves into its groundbreaking experience leading four research experiments in cell sciences in space. These experiments encompass testing the immune cell response to inflammation in space, monitoring the activity of thousands of genes in immune cells exposed to inflammation over time, and tracking the changes in the lifespan of ribonucleic acid (mRNA) between space and Earth. Additionally, the pavilion simulates the inflammatory response to drug treatment using an immune cell model to explore its potential applications for prevention and early treatment.

The aim of these research experiments, conducted in collaboration with the Saudi Space Authority, as part of the scientific mission of Saudi astronauts Rayyanah Barnawi and Ali Al–Qarni to the International Space Station (ISS), is to contribute to exploratory research and its applications in space medicine to enhance the safety of space explorers and utilize the knowledge gained for the benefit the patient community globally.

The scientific experiments lasted for four days and were overseen by the research team led by Dr. Khaled Saad Abu Khubrah, Head of the Department of Molecular Biomedicine and Research at KFSH&RC, along with Dr. Wijdan Al–Ahmadi from KFSH&RC and Dr. Edward Hattie from the BioServe Space Technologies Center in Colorado, USA.

KFSH&RC is actively pursuing further research in space biomedical science to gain a more comprehensive understanding of the effects of gravity deficiency and cosmic radiation on the human body. They aim to leverage the unique space environment, which provides opportunities for medical experiments that are not feasible on Earth. This includes studying how cells and tissues grow in microgravity conditions, potentially leading to groundbreaking discoveries in disease treatments and opening new avenues in space medicine.

KFSH&RC is globally renowned for its specialized healthcare services and its leadership in innovation. It stands as an advanced centre for medical research and education, aiming to advance medical technologies and raise the standard of healthcare worldwide through partnerships with prominent local, regional, and international institutions in clinical, research, and educational fields.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at

https://prdesk.globenewswire.com/api/ResourceLibraryFile/DownloadFile?source=pnr&Id=78eba5fa–19d6–437c–ab42–c9a09636e91e

https://prdesk.globenewswire.com/api/ResourceLibraryFile/DownloadFile?source=pnr&Id=c30c198b–dd13–4d48–8b8c–6667eda49b45

GLOBENEWSWIRE (Distribution ID )